F · Healthcare

Theravance Biopharma Inc (0TB)

Biotechnology

Theravance Biopharma Inc (0TB) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 0TB

P/E ratio

25.00

Theravance Biopharma Inc (0TB) — FAQ

What is 0TB's P/E ratio?

The price-to-earnings (P/E) ratio for Theravance Biopharma Inc (0TB) is 25.00 (data as of 2026-05-24).

Does Theravance Biopharma Inc pay a dividend?

Dividend yield is not available in the current snapshot for Theravance Biopharma Inc (0TB). Check the MyAverix Finance app for the latest dividend data.

What sector is Theravance Biopharma Inc in?

Theravance Biopharma Inc (0TB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 0TB listed on?

0TB is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)